Want to see AU:NGS full AI Analyst Report?
Top Page
Nutritional Growth Solutions Ltd.
(Sydney:NGS)
Select Model
Select Model
Rating:44Neutral
Price Target:
AU$0.02
▲(5.00% Upside)
Action:Reiterated
Date:05/10/26
The score is primarily held down by weak financial performance—shrinking revenue, sharp margin compression, persistent large losses, and ongoing cash burn—despite a return to positive equity. Technical indicators are neutral and do not offset the fundamental risks, and valuation is constrained by negative earnings and no dividend support.
Positive Factors
Improved Equity Position
Return to positive equity in 2025 provides a meaningful structural improvement to the capital base. A positive equity cushion reduces immediate insolvency risk, improves creditor confidence, and modestly extends runway versus a persistently negative equity position, aiding medium-term stability.
Negative Factors
Shrinking Revenue Trend
Sustained top-line decline erodes the foundation for recovery: lower sales limit the ability to cover fixed costs, reduce bargaining power with suppliers, and lengthen time to breakeven. Without reversing revenue trends, margin fixes and cash generation will be hard to sustain over the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
Improved Equity Position
Return to positive equity in 2025 provides a meaningful structural improvement to the capital base. A positive equity cushion reduces immediate insolvency risk, improves creditor confidence, and modestly extends runway versus a persistently negative equity position, aiding medium-term stability.
Read all positive factors
Nutritional Growth Solutions Ltd. (NGS) vs. iShares MSCI Australia ETF (EWA)
Market Cap
AU$7.33M
Dividend YieldN/A
Average Volume (3M)283.41K
Price to Earnings (P/E)―
Beta (1Y)-8.53
Revenue Growth-32.83%
EPS Growth83.37%
CountryAU
Employees6
SectorConsumer Defensive
Sector Strength42
IndustryPackaged Foods
Share Statistics
EPS (TTM)-1.07
Shares Outstanding333,093,200
10 Day Avg. Volume24,410
30 Day Avg. Volume283,411
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.10
Price to Sales (P/S)0.01
P/FCF Ratio-0.02
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Nutritional Growth Solutions Ltd. Business Overview & Revenue Model
Company Description
Headquartered in Tel Aviv, Israel, Nutritional Growth Solutions Ltd. is an enterprise focused on developing, producing, and marketing protein supplements specifically tailored for pediatric use. These products reach consumers both domestically and...
Nutritional Growth Solutions Ltd. Financial Statement Overview
Summary
Income Statement
18
Very Negative
Balance Sheet
30
Negative
Cash Flow
12
Very Negative
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.68M | 2.48M | 3.06M | 2.95M | 3.04M |
| Gross Profit | 263.89K | 811.00K | 842.00K | 1.44M | 1.36M |
| EBITDA | -1.66M | -2.45M | -3.01M | -4.32M | -4.71M |
| Net Income | -1.77M | -2.54M | -2.89M | -4.25M | -4.78M |
Balance Sheet | |||||
| Total Assets | 1.79M | 709.00K | 936.00K | 3.03M | 3.44M |
| Cash, Cash Equivalents and Short-Term Investments | 517.35K | 31.00K | 172.00K | 1.52M | 3.00M |
| Total Debt | 504.34K | 162.00K | 362.00K | 37.00K | 73.00K |
| Total Liabilities | 1.55M | 1.37M | 1.11M | 954.00K | 626.97K |
| Stockholders Equity | 240.16K | -658.00K | -177.00K | 2.08M | 2.81M |
Cash Flow | |||||
| Free Cash Flow | -1.03M | -1.93M | -2.35M | -6.98M | -3.74M |
| Operating Cash Flow | -1.25M | -1.93M | -2.35M | -6.97M | -3.69M |
| Investing Cash Flow | 0.00 | 0.00 | 0.00 | -4.00K | -63.06K |
| Financing Cash Flow | 1.77M | 1.78M | 998.00K | 2.21M | 3.42M |
Nutritional Growth Solutions Ltd. Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | AU$206.19M | 23.09 | 56.29% | ― | 174.51% | 265.77% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
56 Neutral | AU$71.53M | 19.29 | 8.70% | ― | 23.29% | ― | |
45 Neutral | AU$30.48M | -0.31 | 19.78% | ― | 6.22% | 39.68% | |
44 Neutral | AU$7.33M | -0.01 | 226.76% | ― | -32.83% | 83.37% | |
43 Neutral | AU$14.96M | -3.33 | -19.17% | ― | 44.25% | 41.58% | |
40 Underperform | AU$12.55M | -2.78 | -41.69% | ― | 53.69% | 45.24% |
* Consumer Defensive Sector Average
AU:NGS
Nutritional Growth Solutions Ltd.
0.02
0.00
0.00%
AU:NOU
Noumi Limited
0.11
-0.02
-12.50%
AU:AHF
Australian Dairy Nutritionals Group
0.02
-0.02
-51.22%
AU:BLS
Bioxyne Limited
0.97
0.52
115.56%
AU:BUB
Bubs Australia Ltd.
0.08
-0.09
-52.35%
AU:NUC
Nuchev Pty Ltd
0.09
-0.07
-45.16%
Nutritional Growth Solutions Ltd. Corporate Events
Balmain Resources Exits Substantial Holding in Nutritional Growth Solutions
Jun 5, 2026
Balmain Resources Pty Ltd has ceased to be a substantial holder in Nutritional Growth Solutions Ltd., after selling 1,169,101 ordinary shares on market. The disposal, completed on 25 May 2026 for proceeds of $31,876.58, reduces Balmain’s vot...
Nutritional Growth Solutions Reports Departure of Director Without Equity Interests
Jun 2, 2026
Nutritional Growth Solutions Limited has notified the ASX that director Rachel Hirsh has ceased to be a director of the company as of 31 May 2026. The filing confirms that Hirsh held no relevant interests in the company’s securities or contr...
Nutritional Growth Solutions Plans Major ASX Capital Raising via Share and Option Issue
May 25, 2026
Nutritional Growth Solutions Ltd. has announced a proposed issue of new securities on the ASX, comprising up to 601,388,890 new fully paid ordinary shares and 25,000,000 options exercisable at $0.025 and expiring on 15 July 2029. The securities ar...
NGS to buy Sprout Organic in move to build global plant-based paediatric nutrition platform
May 25, 2026
Nutritional Growth Solutions has agreed to acquire 100% of Sprout Organic, owner of the world’s first FSANZ-approved 100% organic, plant-based infant formula, in a deal that will create a diversified paediatric nutrition platform from infanc...
Nutritional Growth Solutions Announces Board Change Amid Focus on Children’s Nutrition
May 8, 2026
Nutritional Growth Solutions, a U.S.-based health and nutrition company specialising in clinically tested supplements for children aged three to twelve, is targeting a significant gap in the global nutritional supplements market. The company diffe...
Nutritional Growth Solutions Resets Cost Base and Balance Sheet as Operations Stabilise
Apr 20, 2026
Nutritional Growth Solutions reported a pivotal March quarter marked by a management overhaul, a structural cost reset and the full repayment of all legacy debt, leaving the company debt-free with cash of US$710,000. The cost program removed about...
Nutritional Growth Solutions Updates Australian Registered Office Address
Apr 20, 2026
Nutritional Growth Solutions has updated its registered office address in Australia to Suite 301, 2 Nexus Court, Mulgrave, Victoria, while keeping all other contact details unchanged. The administrative move signals continued structuring of its Au...
Nutritional Growth Solutions Reshapes Leadership as It Explores Corporate Options
Apr 15, 2026
Nutritional Growth Solutions, a U.S.-based health and wellness company, develops and sells clinically tested nutritional supplements specifically formulated for children aged three to twelve. Drawing on two decades of pediatric nutrition research,...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.